Cutaneous manifestations in neurofibromatosis type 1

被引:36
|
作者
Miraglia, E. [1 ]
Moliterni, E. [1 ]
Lacovino, C. [1 ]
Roberti, V [1 ]
Laghi, A. [1 ]
Moramarco, A. [2 ]
Giustini, S. [1 ]
机构
[1] Sapienza Univ Rome, Dermatol Clin, Rome, Italy
[2] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy
来源
CLINICA TERAPEUTICA | 2020年 / 171卷 / 05期
关键词
Cafe-au-lait macules; cutaneous manifestations; freckling; neurofibromatosis type 1; neurofibroma; neurofibromin; RETINAL MICROVASCULAR ABNORMALITIES; AU LAIT MACULES; POLIOSIS CIRCUMSCRIPTA; BECKERS NEVUS; IN-VIVO; NF1; PATIENT; ASSOCIATION; EXPERIENCE; SPOTS;
D O I
10.7417/CT.2020.2242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To better understand the real prevalence of cutaneous manifestations, in Neurofibromatosis type 1. Materials and Methods. We reviewed all clinical charts of 1102 NF1 patients followed by February 1983 to February 2020 at the "Sapienza" University of Rome, Italy. NF1 patients are seen usually every year by a dermatologist. Results. Cafe-au-lait macules were shown in 1063 patients (96.5%), axillary and inguinal freckling in 991 (90%) and neurofibromas in 861 (78.1%). Other skin manifestations included: lipoma (6.2%), nevus anemicus (3.9%), psoriasis (3.4%), spilus nevus (3.2%), juvenile xanthogranuloma ( 3.2%), vitiligo (2.3%), Becker's nevus (1.9%), melanoma (0.7%) and poliosis (0.5%). Conclusions. Neurofibromatosis type 1 is a multisystem disorder primarily involving the skin and nervous system. The clinical manifestations are extremely variable even within a family. This study was performed to delineate the prevalence of cutaneous manifestations in NF1.
引用
收藏
页码:E371 / E377
页数:7
相关论文
共 50 条
  • [41] Pulmonary complications of type 1 neurofibromatosis
    Reviron-Rabec, L.
    Girerd, B.
    Seferian, A.
    Campbell, K.
    Brosseau, S.
    Bergot, E.
    Humbert, M.
    Zalcman, G.
    Montani, D.
    REVUE DES MALADIES RESPIRATOIRES, 2016, 33 (06) : 460 - 473
  • [42] Neurological malignancies in neurofibromatosis type 1
    Eoli, Marica
    Saletti, Veronica
    Finocchiaro, Gaetano
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 554 - 561
  • [43] Neurofibromatosis Type 1 Related Hydrocephalus
    Roth, Jonathan
    Constantini, Shlomi
    NEUROLOGY INDIA, 2021, 69 : S368 - S371
  • [44] THE NEUROFIBROMATOSIS TYPE-1 GENE
    VISKOCHIL, D
    WHITE, R
    CAWTHON, R
    ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 : 183 - 205
  • [45] Horner Syndrome in Neurofibromatosis Type 1
    Lee, Jang Hyun
    Jeen, Yoon-Mi
    Kang, Sang Gue
    Tark, Min Seung
    Kim, Chul Han
    JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (01) : 169 - 170
  • [46] Spectrum of gastrointestinal lesions of neurofibromatosis type 1: a pictorial review
    Garrouche, Nada
    Ben Abdallah, Amel
    Arifa, Nadia
    Hasni, Ibtissem
    Ben Cheikh, Yasser
    Ben Farhat, Waad
    Ben Amor, Sana
    Jemni, Hela
    INSIGHTS INTO IMAGING, 2018, 9 (05): : 661 - 671
  • [47] Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1
    Jendi, Shoeb Kasim
    Khatib, Shuaib
    Mistry, Jagruti
    Wagh, Ashwin
    Vaidya, Kedar
    Kokane, Gauri
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2019, 71 (Suppl 3) : 2087 - 2090
  • [48] Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1
    Rafaela E. Rozza-de-Menezes
    Nicolle C. Gaglionone
    Raquel M. Andrade-Losso
    Orlando H. K. Siqueira
    Lilian M. Almeida
    Kamila da S. Peruzini
    Marco A. C. Guimarães-Filho
    Carolina I. Brum
    Mauro Geller
    Karin S. Cunha
    Orphanet Journal of Rare Diseases, 12
  • [49] Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2
    Simone L. Ardern-Holmes
    Kathryn N. North
    Current Treatment Options in Neurology, 2011, 13 : 529 - 543
  • [50] Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1
    Kallionpaa, Roope A.
    Peltonen, Sirkku
    Le, Kim My
    Martikkala, Eija
    Jaaskelainen, Mira
    Fazeli, Elnaz
    Riihila, Pilvi
    Haapaniemi, Pekka
    Rokka, Anne
    Salmi, Marko
    Leivo, Ilmo
    Peltonen, Juha
    LABORATORY INVESTIGATION, 2024, 104 (01)